STOCK TITAN

CVS Health (NYSE: CVS) grants options and RSUs to top legal executive

Filing Impact
(Very High)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

CVS Health executive Samrat S. Khichi, EVP, CPO and General Counsel, received equity compensation and had shares withheld for taxes. On March 31, 2026, he was granted 80,838 stock options with an exercise price of $71.82 per share, exercisable in three equal annual installments starting March 31, 2027 until expiration on March 31, 2036. He also received 12,531 restricted stock units under the 2017 Incentive Compensation Plan, with restrictions lapsing in three equal installments beginning March 31, 2027. On April 1, 2026, 3,541 shares of common stock at $72.49 per share were surrendered to pay withholding taxes upon RSU vesting, leaving him with 33,421 common shares held directly.

Positive

  • None.

Negative

  • None.
Insider Khichi Samrat S.
Role EVP, CPO and General Counsel
Type Security Shares Price Value
Tax Withholding Common Stock 3,541 $72.49 $257K
Grant/Award Stock Option 80,838 $71.82 $5.81M
Grant/Award Common Stock (Restricted) 12,531 $71.82 $900K
Holdings After Transaction: Common Stock — 33,421 shares (Direct); Stock Option — 80,838 shares (Direct); Common Stock (Restricted) — 38,139 shares (Direct)
Footnotes (1)
  1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
Stock options granted 80,838 options at $71.82/share Grant on March 31, 2026; expire March 31, 2036
Restricted stock units granted 12,531 RSUs Restrictions lapse in three installments starting March 31, 2027
Shares surrendered for taxes 3,541 shares at $72.49/share Tax withholding upon RSU vesting on April 1, 2026
Common shares held after transactions 33,421 shares Direct ownership following April 1, 2026 tax withholding
Option vesting start date March 31, 2027 First of three equal annual installments
Option expiration date March 31, 2036 Final date to exercise granted options
restricted stock units financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
2017 Incentive Compensation Plan financial
"Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan."
withholding taxes financial
"Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units."
Withholding taxes are amounts a payer or government takes out of payments — such as wages, interest, or dividends — before the recipient gets the money, functioning like a cashier keeping part of a bill to pay taxes on your behalf. For investors this matters because it reduces the cash they actually receive, affects net returns and yield calculations, and may require additional paperwork or treaty claims to recover or offset the withheld amount against final tax bills.
stock option financial
"Option becomes exercisable in three equal annual installments, commencing 3/31/2027."
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
vesting and settlement financial
"withholding taxes due upon the vesting and settlement of restricted stock units."
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Khichi Samrat S.

(Last)(First)(Middle)
ONE CVS DRIVE

(Street)
WOONSOCKET RHODE ISLAND 02895

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
CVS HEALTH Corp [ CVS ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP, CPO and General Counsel
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
03/31/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock (Restricted)03/31/2026A(1)12,531A$71.8238,139D
Common Stock04/01/2026F(2)3,541D$72.4933,421D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option(3)$71.8203/31/2026A80,83803/31/202703/31/2036Common Stock80,838$71.8280,838D
Explanation of Responses:
1. Consists of restricted stock units awarded pursuant to Issuer's 2017 Incentive Compensation Plan. Restrictions lapse in three equal installments, commencing 3/31/2027.
2. Surrender of shares in payment of withholding taxes due upon the vesting and settlement of restricted stock units.
3. Option becomes exercisable in three equal annual installments, commencing 3/31/2027.
/s/ Samrat S. Khichi04/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What stock option grant did CVS (CVS) executive Samrat Khichi receive?

Samrat Khichi received a grant of 80,838 stock options with an exercise price of $71.82 per share. These options vest in three equal annual installments starting March 31, 2027 and expire on March 31, 2036, aligning with long-term incentive compensation.

What restricted stock units did CVS (CVS) award to Samrat Khichi?

CVS awarded 12,531 restricted stock units to Samrat Khichi under its 2017 Incentive Compensation Plan. The restrictions on these units lapse in three equal installments, beginning on March 31, 2027, providing a deferred equity-based component to his overall compensation package.

Why were 3,541 CVS (CVS) shares surrendered by Samrat Khichi?

A total of 3,541 CVS common shares were surrendered to cover withholding taxes due upon the vesting and settlement of restricted stock units. This tax-withholding disposition uses shares instead of cash and does not represent an open-market purchase or sale transaction.

How many CVS (CVS) common shares does Samrat Khichi hold after these transactions?

Following these transactions, Samrat Khichi directly holds 33,421 CVS common shares. This figure reflects his position after the 3,541-share surrender for tax withholding tied to restricted stock unit vesting, as reported in the insider filing data.

When do Samrat Khichi’s CVS stock options become exercisable and expire?

The granted stock options become exercisable in three equal annual installments, starting on March 31, 2027. They have an expiration date of March 31, 2036, providing a multi-year window during which the options may be exercised, subject to plan terms.